Akèy › Kansè Utèrin › Maryland › Baltimore
Etid klinik pou Kansè Utèrin nan Baltimore, MD
4 etid pou Kansè Utèrin ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Ap rekriteFaz 3
- Research Site, Baltimore
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Ap rekriteFaz 3
- Research Site, Baltimore
- Research Site, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- The John Hopkins Hospital, Baltimore
Image-Guided Gynecologic Brachytherapy
Ap rekrite
- The SKCCC at Johns Hopkins, Baltimore
Etid Kansè Utèrin nan lòt vil
- Houston, TX8 etid
- New York City, NY6 etid
- Columbus, OH6 etid
- Boston, MA5 etid
- Philadelphia, PA5 etid
- Austin, TX5 etid
- Miami, FL5 etid
- Pittsburgh, PA4 etid
- Providence, RI4 etid
- Orlando, FL4 etid
- Chicago, IL4 etid
- West Palm Beach, FL4 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè pankreyas31 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Obèsite26 etid
- Kansè vejik24 etid
- Ensifizyans kadyak24 etid
- Kansè ovè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.